Divi’s Laboratories Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹819.67 billion
- Book Value:
- Revenue TTM:
- ₹62.66 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹31.49 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Divi’s Laboratories Limited had its IPO on under the ticker symbol 532488.
The company operates in the Other sector and Other industry. Divi’s Laboratories Limited has a staff strength of 0 employees.
Shares of Divi’s Laboratories Limited opened at ₹3740 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹3740 - ₹3848.6, and closed at ₹3785.1.
This is a +1.38% increase from the previous day's closing price.
A total volume of 15,761 shares were traded at the close of the day’s session.
In the last one week, shares of Divi’s Laboratories Limited have increased by +4.18%.
Divi’s Laboratories Limited's Key Ratios
Divi’s Laboratories Limited has a market cap of ₹819.67 billion, indicating a price to book ratio of 10.9471 and a price to sales ratio of 14.7842.
In the last 12-months Divi’s Laboratories Limited’s revenue was ₹62.66 billion with a gross profit of ₹31.49 billion and an EBITDA of ₹23.95 billion. The EBITDA ratio measures Divi’s Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Divi’s Laboratories Limited’s operating margin was 34.87% while its return on assets stood at 15.52% with a return of equity of 22.84%.
In Q3, Divi’s Laboratories Limited’s quarterly earnings growth was a positive 45.6% while revenue growth was a positive 21%.
Divi’s Laboratories Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹66.261 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Divi’s Laboratories Limited’s profitability.
Divi’s Laboratories Limited stock is trading at a EV to sales ratio of 14.4848 and a EV to EBITDA ratio of 35.3041. Its price to sales ratio in the trailing 12-months stood at 14.7842.
Divi’s Laboratories Limited stock pays annual dividends of ₹32 per share, indicating a yield of 0.95% and a payout ratio of 24.15%.
Balance sheet and cash flow metrics
- Total Assets
- ₹144.39 billion
- Total Liabilities
- ₹11.01 billion
- Operating Cash Flow
- Capital Expenditure
- ₹4.73 billion
- Dividend Payout Ratio
Divi’s Laboratories Limited ended 2023 with ₹144.39 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹144.39 billion while shareholder equity stood at ₹127.67 billion.
Divi’s Laboratories Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹11.01 billion in other current liabilities, 530900000.00 in common stock, ₹127.14 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹42.19 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Divi’s Laboratories Limited’s total current assets stands at ₹93.12 billion while long-term investments were ₹0 and short-term investments were ₹60.70 million. Its net receivables were ₹17.93 billion compared to accounts payable of ₹0 and inventory worth ₹30.00 billion.
In 2023, Divi’s Laboratories Limited's operating cash flow was ₹-27076200000.00 while its capital expenditure stood at ₹4.73 billion.
Comparatively, Divi’s Laboratories Limited paid ₹0.24 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Divi’s Laboratories Limited stock is currently trading at ₹3785.1 per share. It touched a 52-week high of ₹3917.3696 and a 52-week low of ₹3917.3696. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹3667.68 and 200-day moving average was ₹3314.47 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5236.4% of the company’s stock are held by insiders while 2510.3% are held by institutions.
Frequently Asked Questions About Divi’s Laboratories Limited
Similar Industry Stocks (Other)
Divi’s Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates for in the United States, Asia, Europe, and internationally. The company also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. In addition, it exports its products. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.